Valganciclovir is activated by HSV-thymidine kinase in transduced cells; the resulting ganciclovir triphosphate is incorporated by cellular DNA polymerases, causing chain termination and death. Killing depends on HSV-TK expression, not on DNA polymerase delta expression.